BioSpace News Archive

Vivos Therapeutics, Inc. announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that it was not in compliance with requirements of Nasdaq Listing Rule 5250 as a result of not having timely filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced a 1-for-30 reverse split of its common stock, effective at 4:01 PM ET.

The Leukemia & Lymphoma Society is proud to announce that its strong financial health and ongoing accountability and transparency have earned LLS a Four-Star Rating from Charity Navigator.

GE Healthcare and MediView XR, Inc. announced their collaboration to integrate medical imaging into mixed reality solutions through the development of the OmnifyXR™ Interventional Suite System.1 MediView’s current technology platform leverages spatial computing and mixed reality, united with medical imaging in combining augmented reality visualization, seamless remote collaboration and evidence-based clinical insights.

The CIRCLES Consortium, consisting of Vanderbilt University, UC Berkeley, Temple University and Rutgers University-Camden, in coordination with Nissan North America and Tennessee Department of Transportation, concluded a five-day open-track experiment on Nov. 18.

Microba Life Sciences Limited is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited has agreed to invest $17.8m to acquire a 19.99% shareholding in Microba.

OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition in New Orleans, LA. Visit booth 2143 to learn more about our unique, flexible model which combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood.

ConcertAI’s TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for medical imaging, recently unveiled first-in-category capabilities in advanced visualization, AI, and an AI solutions partner ecosystem to better meet clinician requirements in complex clinical workflows providing key augmentations enabling better outcomes for their patients.

Siemens Healthineers and Atrium Health, a leading nonprofit health provider known for its top-ranked pediatric, cancer and heart care programs, have announced a multi-year Value Partnership agreement.

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) (a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs) will be presenting at the Emerging Growth Conference on November 30, 2022.